• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全合成人降钙素的研发、化学性质及临床药理学(作者译)

[Development, chemistry, and clinical pharmacology of fully synthetic human calcitonin (author's transl)].

作者信息

Hobitz H

出版信息

Wien Klin Wochenschr. 1982 Feb 5;94(3):67-75.

PMID:7043901
Abstract

The chemistry and identity of fully synthetic human calcitonin are discussed briefly, with particular reference to the evolution of this hormone. The principal effects of the substance on bone demonstrable by clinicochemical means are illustrated by the results of clinicopharmacological studies in patients suffering from Paget's disease. The potential usefulness of calcitonin in the treatment of osteoporosis is exemplified by reference to the relations between sex hormones and calcitonin. The main differences in the acute effects of calcitonin on the kidney and electrolyte balance in healthy persons and patients with Paget's disease are analysed on the basis of data from comparative human pharmacological and clinicopharmacological studies.

摘要

本文简要讨论了全合成人降钙素的化学性质和特性,尤其涉及其激素的演变过程。通过临床化学方法证实的该物质对骨骼的主要作用,以患有佩吉特氏病患者的临床药理学研究结果为例进行说明。通过参考性激素与降钙素之间的关系,举例说明了降钙素在治疗骨质疏松症方面的潜在用途。基于人体比较药理学和临床药理学研究数据,分析了降钙素对健康人和佩吉特氏病患者肾脏及电解质平衡的急性作用的主要差异。

相似文献

1
[Development, chemistry, and clinical pharmacology of fully synthetic human calcitonin (author's transl)].全合成人降钙素的研发、化学性质及临床药理学(作者译)
Wien Klin Wochenschr. 1982 Feb 5;94(3):67-75.
2
[The treatment of Paget's disease of bone with human calcitonin (author's transl)].
Schweiz Rundsch Med Prax. 1978 Jul 25;67(30):1103-7.
3
[Treatment of Paget's disease of bone with salmon calcitonin (author's transl)].鲑鱼降钙素治疗骨佩吉特病(作者译)
Dtsch Med Wochenschr. 1981 Nov 27;106(48):1620-3. doi: 10.1055/s-2008-1070566.
4
Long-term treatment of Paget's disease of bone with salmon calcitonin.鲑鱼降钙素对骨Paget病的长期治疗
Can Med Assoc J. 1977 Nov 5;117(9):1031-4.
5
[The treatment of Paget's disease using salmon thyrocalcitonin. 8 cases (author's transl)].[使用鲑鱼降钙素治疗佩吉特病。8例(作者译)]
Nouv Presse Med. 1978 Nov 25;7(41):3753-6.
6
[Treatment of Paget's disease of bone: diphosphonates or calcitonin?].[骨佩吉特病的治疗:双膦酸盐还是降钙素?]
Schweiz Med Wochenschr. 1981 Apr 11;111(15):518-24.
7
[Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins].[鳗降钙素类似物Asu(1,7)E-CT。与其他合成降钙素相比的人体对照研究]
Minerva Med. 1983 Apr 28;74(18):993-1010.
8
[Comparative studies of the behavior of blood calcium and urinary hydroxyproline after infusion of calcitonin and glucagon in patients with Paget's disease].[佩吉特病患者输注降钙素和胰高血糖素后血钙和尿羟脯氨酸行为的比较研究]
Boll Soc Ital Biol Sper. 1974 Jan 31;50(1-2):55-61.
9
[The value of the calcitonin test in Paget's disease of bone].
Minerva Med. 1981 Apr 7;72(14):865-8.
10
[Treatment of Paget's disease with salmon calcitonin].
Rev Rhum Mal Osteoartic. 1977 Jan;44(1):59-66.

引用本文的文献

1
Superior local tolerability of human versus salmon calcitonin preparations in young healthy volunteers.人降钙素制剂与鲑鱼降钙素制剂在年轻健康志愿者中的局部耐受性比较:人降钙素制剂具有更高的局部耐受性
Eur J Clin Pharmacol. 1991;41(3):211-5. doi: 10.1007/BF00315432.